When it comes to emergency prescribing for ADHD, recent developments in Victoria are making waves. The state has rolled out significant reforms that now empower ‘specialist GPs’ to persist with ADHD prescriptions for their ongoing patients. But that's not all—last week, the Allan Government introduced an innovative initiative that could reshape the landscape of ADHD care across Australia. Starting in September, individuals diagnosed with ADHD will have access to an online emergency prescribing pathway through the Victorian Virtual Emergency Department (VVED). This groundbreaking service allows those in need to quickly obtain urgent repeat prescriptions.
So, what exactly does this new model entail, and what measures are being implemented to ensure safety? Furthermore, how does this initiative compare to similar efforts in other states and territories? Let’s dive deeper into these questions.
What is the Service Aimed to Achieve?
The VVED telehealth service emerges as a response to alarming trends: increasing wait times for specialist appointments, soaring costs, and the clinical dangers associated with suddenly stopping ADHD medications classified under Schedule 8. These abrupt halts can trigger a rebound of symptoms, hinder daily functioning, and lead to serious emotional distress. A representative from the Department of Health explained that the service aims to provide a crucial safety net rather than replace established treatment pathways.
‘The Victorian Virtual Emergency Department offers a secure means for individuals with a confirmed ADHD diagnosis to urgently refill their prescriptions,’ the spokesperson clarified.
How Will Urgent ADHD Prescriptions Be Processed?
Within the VVED, qualified clinicians will authenticate the patient's current medication and dosage before issuing any prescriptions. These prescriptions will be directly sent to the patient’s preferred local pharmacy, ensuring that they are informed about the nearest pharmacy operational at the time of the prescription.
The Department of Health made it clear that this service is not intended to take the place of regular ADHD management. ‘This is strictly for emergencies and will not disrupt the essential ongoing relationship between a patient and their healthcare provider,’ the spokesperson emphasized.
Who Can Use This Service?
The Victorian initiative permits both adults and children aged six and older, who already have an ADHD diagnosis, to leverage this service if they cannot promptly meet with their regular clinician. Importantly, this pathway is restricted to individuals already receiving ADHD medications. The VVED will not initiate new treatments, adjust dosages, or engage in ongoing prescribing.
What Safeguards Are In Place?
All existing regulatory standards and clinical guidelines governing ADHD medications will remain intact throughout the VVED process. ‘The VVED clinicians, including pediatric specialists and psychiatrists, are highly trained and experienced,’ reassured the spokesperson. They will prescribe medications within their professional scope and clinical guidelines.
Additionally, mandatory use of SafeScript for Schedule 8 medications will continue to be a fundamental safeguard. This system allows prescribers and pharmacists to monitor dispensing histories effectively, thereby minimizing the risk of patients acquiring excessive prescriptions from multiple sources.
The Department has reiterated that the responsibility for ongoing ADHD treatment rests with the patient’s usual healthcare provider, positioning the VVED as a temporary support mechanism amid broader efforts to enhance GP engagement in ADHD care.
Rather than handing the prescription directly to the patient, it will be dispatched to their chosen local pharmacy, which they will be informed about when the prescription is issued.
A Part of a Nationwide Shift
Victoria’s online emergency model is not an isolated change; it aligns with a broader national movement aimed at redistributing ADHD care away from a heavy reliance on specialist services. Since December 1, 2025, ‘specialist GPs’ in Queensland have been empowered to initiate, modify, and continue stimulant treatments for adults suffering from ADHD following updated guidelines from Queensland Health.
As of today (February 11), ACT Health announced new prescribing protocols, allowing GPs who have undergone approved training to continue prescribing ADHD medications for eligible patients without necessitating repeated evaluations from a psychiatrist, pediatrician, or neurologist. Other jurisdictions like New South Wales, Western Australia, and South Australia are set to introduce comparable reforms in the near future.
Across Australia, governments are working diligently to shorten wait times, reduce out-of-pocket expenses, and integrate ADHD care more effectively within primary healthcare frameworks, all while maintaining stringent oversight of Schedule 8 stimulants such as methylphenidate, dexamfetamine, and lisdexamfetamine through authorized prescribing systems and real-time prescription monitoring. Meanwhile, non-stimulant ADHD medications remain classified under Schedule 4 and will continue to be prescribed under existing guidelines.
For those seeking further insights, check out the PSA's online module titled "ADHD Explained" for a deeper understanding.
